NK/ILC1 cells mediate neuroinflammation and brain pathology following congenital CMV infection.


Journal

The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R

Informations de publication

Date de publication:
03 05 2021
Historique:
received: 16 07 2020
revised: 11 12 2020
accepted: 29 01 2021
entrez: 25 2 2021
pubmed: 26 2 2021
medline: 5 10 2021
Statut: ppublish

Résumé

Congenital human cytomegalovirus (cHCMV) infection of the brain is associated with a wide range of neurocognitive sequelae. Using infection of newborn mice with mouse cytomegalovirus (MCMV) as a reliable model that recapitulates many aspects of cHCMV infection, including disseminated infection, CNS infection, altered neurodevelopment, and sensorineural hearing loss, we have previously shown that mitigation of inflammation prevented alterations in cerebellar development, suggesting that host inflammatory factors are key drivers of neurodevelopmental defects. Here, we show that MCMV infection causes a dramatic increase in the expression of the microglia-derived chemokines CXCL9/CXCL10, which recruit NK and ILC1 cells into the brain in a CXCR3-dependent manner. Surprisingly, brain-infiltrating innate immune cells not only were unable to control virus infection in the brain but also orchestrated pathological inflammatory responses, which lead to delays in cerebellar morphogenesis. Our results identify NK and ILC1 cells as the major mediators of immunopathology in response to virus infection in the developing CNS, which can be prevented by anti-IFN-γ antibodies.

Identifiants

pubmed: 33630019
pii: 211828
doi: 10.1084/jem.20201503
pmc: PMC7918636
pii:
doi:

Substances chimiques

Chemokine CXCL10 0
Chemokine CXCL9 0
Cxcr3 protein, mouse 0
Receptors, CXCR3 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDCD NIH HHS
ID : R01 DC015980
Pays : United States

Informations de copyright

© 2021 Kveštak et al.

Déclaration de conflit d'intérêts

Disclosures: The authors declare no competing interests exist.

Références

Neuroscience. 2001;105(1):7-17
pubmed: 11483296
PLoS Pathog. 2013;9(9):e1003611
pubmed: 24086132
Methods Mol Biol. 2016;1415:245-62
pubmed: 27115637
J Clin Virol. 2009 Dec;46 Suppl 4:S22-6
pubmed: 19766534
Microbes Infect. 2003 Nov;5(13):1263-77
pubmed: 14623023
Nucleic Acids Res. 2019 Jan 8;47(D1):D766-D773
pubmed: 30357393
J Virol. 2004 Jan;78(2):585-94
pubmed: 14694090
J Virol. 1996 Dec;70(12):8833-49
pubmed: 8971012
Curr Protoc Immunol. 2018 Aug;122(1):e51
pubmed: 30044539
Eur J Immunol. 2018 Jun;48(6):950-964
pubmed: 29500823
Clin Microbiol Rev. 2004 Oct;17(4):942-64, table of contents
pubmed: 15489356
Med Microbiol Immunol. 2019 Aug;208(3-4):487-494
pubmed: 30923899
Immunity. 2004 Jul;21(1):107-19
pubmed: 15345224
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
N Engl J Med. 2015 Mar 5;372(10):933-43
pubmed: 25738669
Cell. 2018 Aug 23;174(5):1054-1066
pubmed: 30142344
Nat Immunol. 2016 Jul;17(7):797-805
pubmed: 27135602
J Exp Med. 1998 Feb 16;187(4):609-18
pubmed: 9463411
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Neuroinflammation. 2004 Jul 30;1(1):14
pubmed: 15285801
Med Microbiol Immunol. 2015 Jun;204(3):367-82
pubmed: 25776081
Cell. 2017 Nov 2;171(4):795-808.e12
pubmed: 29056343
J Immunol. 2008 Jan 15;180(2):1098-106
pubmed: 18178850
Microorganisms. 2020 Jan 25;8(2):
pubmed: 31991822
Neuron. 1999 Jan;22(1):103-14
pubmed: 10027293
Methods Mol Biol. 2008;415:127-49
pubmed: 18370152
Nucleic Acids Res. 2013 Jan;41(Database issue):D1040-6
pubmed: 23203888
Cell Mol Life Sci. 2016 Jan;73(2):291-303
pubmed: 26499980
Mult Scler. 2006 Oct;12(5):558-64
pubmed: 17086900
J Immunol. 2015 May 1;194(9):4251-64
pubmed: 25795755
Nucleic Acids Res. 2003 Sep 15;31(18):5349-55
pubmed: 12954771
Development. 2014 Nov;141(21):4031-41
pubmed: 25336734
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4637-4642
pubmed: 30782788
Viruses. 2018 Dec 06;10(12):
pubmed: 30563202
J Interferon Cytokine Res. 2007 Jul;27(7):599-605
pubmed: 17651021
PLoS Pathog. 2013 Mar;9(3):e1003200
pubmed: 23505367
Nucleic Acids Res. 2020 Jan 8;48(D1):D9-D16
pubmed: 31602479
Genomics. 2003 Dec;82(6):637-43
pubmed: 14611805
Curr Biol. 1999 Apr 22;9(8):445-8
pubmed: 10226030
J Virol. 2017 Mar 29;91(8):
pubmed: 28122986
J Immunol. 2008 Aug 1;181(3):2111-23
pubmed: 18641350
Lab Anim. 2009 Apr;43(2):165-73
pubmed: 19015179
Immunity. 2017 Jun 20;46(6):891-909
pubmed: 28636958
Bioinformatics. 2016 Oct 1;32(19):3047-8
pubmed: 27312411
Clin Infect Dis. 2013 Dec;57 Suppl 4:S178-81
pubmed: 24257422
J Exp Med. 1991 May 1;173(5):1053-63
pubmed: 1850779
Front Immunol. 2015 Oct 30;6:539
pubmed: 26579119
J Exp Med. 2014 Mar 10;211(3):563-77
pubmed: 24516120
Nucleic Acids Res. 2014 Jan;42(Database issue):D699-704
pubmed: 24297253
J Immunol. 2011 May 15;186(10):5766-71
pubmed: 21490162
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Nucleic Acids Res. 2017 Jan 4;45(D1):D128-D134
pubmed: 27794554
BMC Bioinformatics. 2015 Jul 19;16:224
pubmed: 26187896
Curr Protoc Bioinformatics. 2015 Sep 03;51:11.14.1-11.14.19
pubmed: 26334920
Nat Neurosci. 2017 Feb;20(2):136-144
pubmed: 28092660
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
J Clin Invest. 1999 Dec;104(12):1715-22
pubmed: 10606625
F1000Res. 2018 Aug 24;7:1338
pubmed: 30254741
Nat Rev Neurosci. 2019 May;20(5):298-313
pubmed: 30923348
Annu Rev Immunol. 2019 Apr 26;37:73-95
pubmed: 31026414
J Exp Med. 2008 Feb 18;205(2):423-35
pubmed: 18268036
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Immunity. 2012 Jan 27;36(1):55-67
pubmed: 22261438
Methods Mol Biol. 2014;1119:289-310
pubmed: 24639229
Nucleic Acids Res. 2020 Jan 8;48(D1):D1-D8
pubmed: 31906604
Front Immunol. 2019 Oct 10;10:2337
pubmed: 31649664
Front Cell Neurosci. 2018 Oct 02;12:329
pubmed: 30333729
Mol Cell Neurosci. 2004 Dec;27(4):489-96
pubmed: 15555926
J Virol. 2004 Jul;78(14):7536-44
pubmed: 15220428

Auteurs

Daria Kveštak (D)

Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.

Vanda Juranić Lisnić (V)

Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.

Berislav Lisnić (B)

Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.

Jelena Tomac (J)

Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.

Mijo Golemac (M)

Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.

Ilija Brizić (I)

Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.

Daniela Indenbirken (D)

Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.

Maja Cokarić Brdovčak (M)

Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.

Giovanni Bernardini (G)

Department of Molecular Medicine, Faculty of Pharmacy and Medicine, University of Rome "Sapienza", Rome, Italy.

Fran Krstanović (F)

Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.

Carmen Rožmanić (C)

Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.

Adam Grundhoff (A)

Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.

Astrid Krmpotić (A)

Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.

William J Britt (WJ)

Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL.

Stipan Jonjić (S)

Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH